| |
| |
|
| Insider
Information: |
Gujrathi Sheila |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
330,425 |
|
|
Indirect Shares
|
4,048,242 |
|
|
| Direct
Value |
$255,871 |
|
|
|
Indirect Value
|
$2,704,226 |
|
|
| Total
Shares |
4,378,667 |
|
|
| Total
Value |
$2,960,097 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Receptos, Inc. |
RCPT |
Chief Medical Officer |
2015-08-27 |
0 |
|
0 |
Premium* |
|
|
Gossamer Bio Inc |
GOSS |
President & CEO, Direc... |
2020-02-14 |
189,500 |
2020-02-14 |
4,048,242 |
Premium* |
|
|
Janux Therapeutics, Inc. |
JANX |
|
2024-02-29 |
108,028 |
|
0 |
Premium* |
|
|
Ventyx Biosciences, Inc. |
VTYX |
Director |
2021-10-25 |
32,897 |
2021-10-25 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| JANX |
Janux Therapeutics, Inc. |
|
– • – |
2024-02-29 |
4 |
A |
$0.00 |
$0 |
D/D |
2,986 |
108,028 |
0 |
- |
|
| VTYX |
Ventyx Biosciences, Inc. |
Director |
– • – |
2021-10-25 |
4 |
A |
$0.00 |
$0 |
D/D |
32,897 |
32,897 |
0 |
- |
|
| JANX |
Janux Therapeutics, Inc. |
Director |
– • – |
2021-06-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
105,042 |
|
- |
|
| GOSS |
Gossamer Bio Inc |
President & CEO |
• • – |
2020-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
189,500 |
189,500 |
0 |
- |
|
| GOSS |
Gossamer Bio Inc |
President & CEO |
• • – |
2019-09-27 |
4 |
B |
$16.80 |
$167,980 |
I/I |
10,000 |
4,048,242 |
2.66 |
- |
|
| GOSS |
Gossamer Bio Inc |
President & CEO |
• • – |
2019-02-12 |
4 |
A |
$0.00 |
$0 |
I/I |
62,030 |
4,038,242 |
0 |
- |
|
| RCPT |
Receptos, Inc. |
Chief Medical Officer |
• – – |
2015-08-27 |
4 |
D |
$0.00 |
$0 |
D/D |
(12,500) |
0 |
0 |
- |
|
| RCPT |
Receptos, Inc. |
Chief Medical Officer |
• – – |
2015-08-25 |
4 |
D |
$0.00 |
$0 |
D/D |
(120,661) |
12,500 |
0 |
- |
|
| RCPT |
Receptos, Inc. |
Chief Medical Officer |
• – – |
2015-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
133,161 |
0 |
- |
|
| RCPT |
Receptos, Inc. |
Chief Medical Officer |
• – – |
2014-11-11 |
4 |
AS |
$108.99 |
$3,269,700 |
D/D |
(30,000) |
120,661 |
0 |
- |
|
| RCPT |
Receptos, Inc. |
Chief Medical Officer |
• – – |
2014-09-22 |
4 |
AS |
$61.45 |
$1,843,500 |
D/D |
(30,000) |
150,661 |
0 |
- |
|
| RCPT |
Receptos, Inc. |
Chief Medical Officer |
• – – |
2013-05-14 |
4 |
OE |
$5.25 |
$69,998 |
D/D |
13,333 |
180,661 |
0 |
- |
|
| RCPT |
Receptos, Inc. |
Chief Medical OfficerOfficer |
• – – |
2013-05-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
167,328 |
|
- |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
